ZS Pharma is a publicly traded biopharmaceutical company with offices in San Mateo, California and Coppell, Texas. ZS Pharma recently submitted a New Drug Application to the FDA for its lead therapeutic candidate, ZS-9 for the treatment of hyperkalemia, supported by the results of multiple Phase 3 clinical trials which demonstrated its ability to safely and effectively remove excess potassium from the blood and maintain normal potassium levels. ZS Pharma is also pursuing the discovery of additional drug candidates that utilize its novel selective ion-trap technology for the treatment of kidney and liver diseases.
Product Categories
- Pharmaceuticals